Doi.org/10.1074/jbc.M116.752493: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    4 August 2022

    • curprev 08:1708:17, 4 August 2022179.215.124.0 talk 541 bytes +541 Created page with "== Target Article == Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARchar(39) (peroxisome proliferator-activated receptor char(39)) and RUNX2 (runt-related transcription factor 2) ; Lance A Stechschulte Chunxi Ge Terry D Hinds Jr Edwin R Sanchez Renny T Franceschi Beata Lecka-; NULL; 09/29/2016; https://doi.org/10.1074/jbc.M116.752493 == Reasons == Note: Reasons not yet here included,..."